Literature DB >> 11966584

MRI appearances of the sphenoid sinus at the late follow-up of trans-sphenoidal surgery for pituitary macroadenoma.

S E J Connor1, N P Deasy.   

Abstract

We aimed to demonstrate the appearances of the sphenoid sinus on MRI performed later than 2 years post- transsphenoidal surgery (TSS). We retrospectively reviewed 47 patients in whom follow-up MRI scans had been performed at least 2 years post-TSS. We specifically reviewed the clinical and imaging of those patients in whom the sphenoid sinus was filled with signal abnormality or masses were present arising from the sinus roof and classified them as tumour or indeterminate abnormalities on imaging criteria. We documented other clinicoradiological details. Twelve of 47 patients demonstrated sphenoid sinus filling or sinus roof masses and in six of 12 patients it was possible to classify them as tumourous using imaging and clinical criteria. The indeterminate and non-tumourous sphenoid sinus abnormalities most frequently had a T1-weighted signal similar to subsellar tumour and displayed rim enhancement and thus could not be reliably distinguished from tumourous abnormality on the basis of signal or enhancement characteristics. The presence of a well-defined surgical defect in the sella floor was associated with resolution of abnormality on MRI follow-up. We concluded MRI findings of sphenoid sinus filling or sinus roof masses are present in approximately 26% of scans performed longer than 2 years post-TSS. Half of these are of indeterminate origin and follow-up is required to discriminate tumour from non- tumour with certainty. A well-defined surgical defect in the sella floor is, however, suggestive of a non-tumourous abnormality.

Entities:  

Mesh:

Year:  2002        PMID: 11966584     DOI: 10.1046/j.1440-1673.2001.00991.x

Source DB:  PubMed          Journal:  Australas Radiol        ISSN: 0004-8461


  4 in total

Review 1.  Guidelines in the management of CNS tumors.

Authors:  Navid Redjal; Andrew S Venteicher; Danielle Dang; Andrew Sloan; Remi A Kessler; Rebecca R Baron; Constantinos G Hadjipanayis; Clark C Chen; Mateo Ziu; Jeffrey J Olson; Brian V Nahed
Journal:  J Neurooncol       Date:  2021-02-21       Impact factor: 4.130

2.  Sinonasal outcomes associated with the use of BioGlue® in endoscopic transsphenoidal pituitary surgery.

Authors:  Cathal John Hannan; Deirdre Nolan; Paula Corr; Michael Amoo; Daniel Murray; Seamus Looby; Mohsen Javadpour
Journal:  Neurosurg Rev       Date:  2022-01-27       Impact factor: 3.042

3.  Are T2-weighted images more useful than T1-weighted contrast-enhanced images in assessment of postoperative sella and parasellar region?

Authors:  Joanna Bladowska; Anna Biel; Anna Zimny; Katarzyna Lubkowska; Grazyna Bednarek-Tupikowska; Tomasz Sozanski; Urszula Zaleska-Dorobisz; Marek Sasiadek
Journal:  Med Sci Monit       Date:  2011-10

4.  MRI image characteristics of materials implanted at sellar region after transsphenoidal resection of pituitary tumours.

Authors:  Joanna Bladowska; Grażyna Bednarek-Tupikowska; Violetta Sokolska; Roman Badowski; Krzysztof Moroń; Wiesław Bonicki; Marek Sąsiadek
Journal:  Pol J Radiol       Date:  2010-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.